Categories
Astec LifeSciences Limited — Updates, 27-04-2026: Press Release
27-04-2026 · 08:18 pm
Astec LifeSciences reports robust Q4FY26 with 34% revenue growth to ₹161.3 Cr and EBITDA jumping 87% to ₹11.8 Cr, significantly reducing losses. Full-year FY26 also saw improved income and an EBITDA turnaround to ₹0.5 Cr.
No comments yet. Be the first to comment!